The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.

<h4>Background</h4>Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries.<h4>Aims</h4>To determine whether public sector inappropriate ant...

Full description

Bibliographic Details
Main Authors: Kathleen Anne Holloway, Laura Rosella, David Henry
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0152020
id doaj-75e597e1bcaa4f4380433ef09a044e22
record_format Article
spelling doaj-75e597e1bcaa4f4380433ef09a044e222021-03-04T06:55:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015202010.1371/journal.pone.0152020The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.Kathleen Anne HollowayLaura RosellaDavid Henry<h4>Background</h4>Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries.<h4>Aims</h4>To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies.<h4>Materials and methods</h4>Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing.<h4>Results</h4>Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of ≥20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys.<h4>Conclusions</h4>Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries.https://doi.org/10.1371/journal.pone.0152020
collection DOAJ
language English
format Article
sources DOAJ
author Kathleen Anne Holloway
Laura Rosella
David Henry
spellingShingle Kathleen Anne Holloway
Laura Rosella
David Henry
The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
PLoS ONE
author_facet Kathleen Anne Holloway
Laura Rosella
David Henry
author_sort Kathleen Anne Holloway
title The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
title_short The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
title_full The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
title_fullStr The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
title_full_unstemmed The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.
title_sort impact of who essential medicines policies on inappropriate use of antibiotics.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2016-01-01
description <h4>Background</h4>Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries.<h4>Aims</h4>To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies.<h4>Materials and methods</h4>Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing.<h4>Results</h4>Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of ≥20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys.<h4>Conclusions</h4>Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries.
url https://doi.org/10.1371/journal.pone.0152020
work_keys_str_mv AT kathleenanneholloway theimpactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT laurarosella theimpactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT davidhenry theimpactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT kathleenanneholloway impactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT laurarosella impactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
AT davidhenry impactofwhoessentialmedicinespoliciesoninappropriateuseofantibiotics
_version_ 1714808405728690176